首页> 美国卫生研究院文献>World Journal of Virology >Intrinsic host restriction factors of human cytomegalovirus replication and mechanisms of viral escape
【2h】

Intrinsic host restriction factors of human cytomegalovirus replication and mechanisms of viral escape

机译:人类巨细胞病毒复制的内在宿主限制因素和病毒逃逸机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Before a pathogen even enters a cell, intrinsic immune defenses are active. This first-line defense is mediated by a variety of constitutively expressed cell proteins collectively termed “restriction factors” (RFs), and they form a vital element of the immune response to virus infections. Over time, however, viruses have evolved in a variety ways so that they are able to overcome these RF defenses via mechanisms that are specific for each virus. This review provides a summary of the universal characteristics of RFs, and goes on to focus on the strategies employed by some of the most important RFs in their attempt to control human cytomegalovirus (HCMV) infection. This is followed by a discussion of the counter-restriction mechanisms evolved by viruses to circumvent the host cell’s intrinsic immune defenses. RFs include nuclear proteins IFN-γ inducible protein 16 (IFI16) (a Pyrin/HIN domain protein), Sp100, promyelocytic leukemia, and hDaxx; the latter three being the keys elements of nuclear domain 10 (ND10). IFI16 inhibits the synthesis of virus DNA by down-regulating UL54 transcription - a gene encoding a CMV DNA polymerase; in response, the virus antagonizes IFI16 via a process involving viral proteins UL97 and pp65 (pUL83), which results in the mislocalizing of IFI16 into the cytoplasm. In contrast, viral regulatory proteins, including pp71 and IE1, seek to modify or disrupt the ND10 proteins and thus block or reverse their inhibitory effects upon virus replication. All in all, detailed knowledge of these HCMV counter-restriction mechanisms will be fundamental for the future development of new strategies for combating HCMV infection and for identifying novel therapeutic agents.
机译:在病原体甚至进入细胞之前,内在的免疫防御系统就处于活跃状态。一线防御是由多种组成性表达的细胞蛋白(统称为“限制因子”(RF))介导的,它们构成了对病毒感染的免疫反应的重要组成部分。但是,随着时间的流逝,病毒已经以多种方式进化,因此它们能够通过针对每种病毒的特定机制来克服这些RF防御。这篇综述总结了RF的普遍特征,并继续着重于一些最重要的RF在控制人类巨细胞病毒(HCMV)感染中所采用的策略。随后讨论病毒进化出的反限制机制,以规避宿主细胞的内在免疫防御。 RFs包括核蛋白IFN-γ诱导蛋白16(IFI16)(一种Pyrin / HIN域蛋白),Sp100,早幼粒细胞白血病和hDaxx。后三个是核域10(ND10)的关键要素。 IFI16通过下调UL54转录(一种编码CMV DNA聚合酶的基因)来抑制病毒DNA的合成。作为响应,该病毒通过涉及病毒蛋白UL97和pp65(pUL83)的过程拮抗IFI16,这导致IFI16错位到细胞质中。相反,包括pp71和IE1在内的病毒调节蛋白试图修饰或破坏ND10蛋白,从而阻断或逆转其对病毒复制的抑制作用。总而言之,对这些HCMV反限制机制的详细了解对于未来开发对抗HCMV感染的新策略以及确定新型治疗剂至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号